High potency statins pose 'bigger risk' of kidney damage
Patients taking “high potency” statins have a significantly higher risk of being admitted to hospital with acute kidney injury (AKI) than those who use “low potency” drugs, researchers said.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units